P194-1328 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-6-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1,6-dihydropyrimidin-1-yl]acetamide

P194-1328 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-6-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1,6-dihydropyrimidin-1-yl]acetamide
P194-1328 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-6-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1,6-dihydropyrimidin-1-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P194-1328
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-6-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1,6-dihydropyrimidin-1-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P194-1328

Molecular Formula

C24H24N4O4 (C24 H24 N4 O4)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-methyl-6-oxo-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)-1,6-dihydropyrimidin-1-yl]acetamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-2-[4-methyl-6-oxo-2-(1234-tetrahydroisoquinolin-2-yl)-16-dihydropyrimidin-1-yl]acetamide

SMILES

CC(N=C(N1CC(Nc(cc2)cc3c2OCCO3)=O)N(CC2)Cc3c2cccc3)=CC1=O

InChI

InChI=1S/C24H24N4O4/c1-16-12-23(30)28(24(25-16)27-9-8-17-4-2-3-5-18(17)14-27)15-22(29)26-19-6-7-20-21(13-19)32-11-10-31-20/h2-7,12-13H,8-11,14-15H2,1H3,(H,26,29)

InChI Key

VEJNRCGBUNWLRO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28996721

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.977

Distribution Coefficient, logD

1.977

Water Solubility, LogSw

-2.75

Polar Surface Area

67.590

Acid Dissociation Constant (pKa)

11.65

Base Dissociation Constant (pKb)

1.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

P194-1328 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P194-1328 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P194-1328?
Check Price and Availability of P194-1328, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P194-1328 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P194-1328
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P194-1328
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P194-1328 available by request